ReviewInvestigational new drugs2025

Progress of KRAS G12C inhibitors in the treatment of refractory colorectal cancer and strategies for drug resistance response.

Peiyuan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.